Literature DB >> 26219720

The Role of Tissue Non-specific Alkaline Phosphatase (TNAP) in Neurodegenerative Diseases: Alzheimer's Disease in the Focus.

Katherine A B Kellett1, Nigel M Hooper.   

Abstract

Tissue non-specific alkaline phosphatase (TNAP) is present on neuronal membranes and induces neuronal toxicity via tau dephosphorylation; a mechanism which could play a role in the neuronal loss seen in Alzheimer's disease (AD). TNAP increases in the plasma following brain injury and cerebrovascular disease. In this chapter we summarise our previous work which looked at changes in TNAP activity in the brain and plasma of AD individuals and discuss whether these changes may be reflective of neuronal loss. Our data demonstrate that TNAP activity is significantly increased in the brain in both the sporadic and familial forms of AD and that TNAP activity is significantly increased in the plasma in AD patients. In addition, we describe a significant inverse correlation between plasma TNAP activity and cognitive function in AD. Using these data we propose a model for TNAP-induced neurodegeneration in AD resulting from tau dephosphorylation following secretion of tau from neuronal cells.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26219720     DOI: 10.1007/978-94-017-7197-9_17

Source DB:  PubMed          Journal:  Subcell Biochem        ISSN: 0306-0225


  9 in total

1.  X-ray crystal structure of Vibrio alkaline phosphatase with the non-competitive inhibitor cyclohexylamine.

Authors:  Bjarni Ásgeirsson; Sigurbjörn Markússon; Sigríður S Hlynsdóttir; Ronny Helland; Jens G Hjörleifsson
Journal:  Biochem Biophys Rep       Date:  2020-10-15

2.  Profiling Microglia in a Mouse Model of Machado-Joseph Disease.

Authors:  Ana Bela Campos; Sara Duarte-Silva; Bruno Fernandes; Sofia Pereira das Neves; Fernanda Marques; Andreia Teixeira-Castro; Andreia Neves-Carvalho; Daniela Monteiro-Fernandes; Camila Cabral Portugal; Renato Socodato; Teresa Summavielle; António Francisco Ambrósio; João Bettencourt Relvas; Patrícia Maciel
Journal:  Biomedicines       Date:  2022-01-23

Review 3.  Alkaline Phosphatase: An Old Friend as Treatment Target for Cardiovascular and Mineral Bone Disorders in Chronic Kidney Disease.

Authors:  Mathias Haarhaus; Giuseppe Cianciolo; Simona Barbuto; Gaetano La Manna; Lorenzo Gasperoni; Giovanni Tripepi; Mario Plebani; Maria Fusaro; Per Magnusson
Journal:  Nutrients       Date:  2022-05-19       Impact factor: 6.706

4.  Dephosphorylation Passivates the Seeding Activity of Oligomeric Tau Derived From Alzheimer's Brain.

Authors:  Ruozhen Wu; Longfei Li; Ruirui Shi; Yan Zhou; Nana Jin; Jianlan Gu; Yunn Chyn Tung; Fei Liu; Dandan Chu
Journal:  Front Mol Neurosci       Date:  2021-05-13       Impact factor: 5.639

Review 5.  Alkaline Phosphatase, an Unconventional Immune Protein.

Authors:  Bethany A Rader
Journal:  Front Immunol       Date:  2017-08-03       Impact factor: 7.561

Review 6.  Pharmacologic epigenetic modulators of alkaline phosphatase in chronic kidney disease.

Authors:  Mathias Haarhaus; Dean Gilham; Ewelina Kulikowski; Per Magnusson; Kamyar Kalantar-Zadeh
Journal:  Curr Opin Nephrol Hypertens       Date:  2020-01       Impact factor: 3.416

Review 7.  Dangerous Liaisons: Tau Interaction with Muscarinic Receptors.

Authors:  Adrianna Wysocka; Ewelina Palasz; Marta Steczkowska; Grazyna Niewiadomska
Journal:  Curr Alzheimer Res       Date:  2020       Impact factor: 3.498

Review 8.  Markers and Biomarkers of Endothelium: When Something Is Rotten in the State.

Authors:  Nikolay V Goncharov; Alexander D Nadeev; Richard O Jenkins; Pavel V Avdonin
Journal:  Oxid Med Cell Longev       Date:  2017-11-23       Impact factor: 6.543

Review 9.  Role of purinergic receptors in the Alzheimer's disease.

Authors:  Marek Cieślak; Andrzej Wojtczak
Journal:  Purinergic Signal       Date:  2018-10-25       Impact factor: 3.765

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.